Fundraising Fox
Cambridge Technologies
Worthington, US · Minnesota LLC
Find your way into Cambridge Technologies
Sign up to see every warm intro you have to Cambridge Technologies
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Cambridge Technologies team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Cambridge Technologies provides veterinarians with next-generation diagnostics and custom-manufactured autogenous vaccines for production animals, including beef and dairy cattle, swine, and small ruminants. Using its "Precision Vaccinology" process, the company sequences herd samples to identify pathogens and formulates herd-specific vaccines to prevent disease and reduce antibiotic dependence.
Founders & leadership
Board
Reported raises · per SEC filings
Form D private placements$3.5M disclosed across 1 round · 2018
▶$3.5MraisedJan 2018 · 1 investors · OtherRule 506(b)
- Wayne FreeseExecutive Officer, Director
- Carl Frank StonerDirector
- Randy SimonsonExecutive Officer, Director
- Marc FreeseDirector
- Donna TimsExecutive Officer, Director
- James Douglas RasmussenDirector
- Reed LeitingDirector
- Offering amount
- $3.5M
- Amount sold
- $3.5M
- Minimum investment
- $3.5M
- First sale
- Jan 2018
- Incorporated
- Limited Liability Company, Minnesota
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 2 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| Department of Agriculture (USDA) | Phase II | 2019 | $641.8K |
| Department of Agriculture (USDA) | Phase I | 2018 | $100K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Cambridge Technologies do?
- Cambridge Technologies provides veterinarians with next-generation diagnostics and custom-manufactured autogenous vaccines for production animals, including beef and dairy cattle, swine, and small ruminants. Using its "Precision Vaccinology" process, the company sequences herd samples to identify pathogens and formulates herd-specific vaccines to prevent disease and reduce antibiotic dependence.
- How much funding has Cambridge Technologies raised?
- Cambridge Technologies has disclosed $3.5M raised across 1 round.
- Where is Cambridge Technologies headquartered?
- Cambridge Technologies is headquartered in Worthington, US.